NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

• Published in: Доповіді НАН України
• Date: 2018
• Main Authors: Sokolova, L.K., Pushkarev, V.M., Belchina, Yu.B., Pushkarev, V.V., Furmanova, O.V., Cherviakova, S.A., Kovzun, O.I., Tronko, M.D.
• Format: Article
• Language: English
• Published: Видавничий дім "Академперіодика" НАН України 2018
• Subjects: Медицина
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/144557
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment / L.K. Sokolova, V.M. Pushkarev, Yu.B. Belchina, V.V. Pushkarev, O.V. Furmanova, S.A. Cherviakova, O.I. Kovzun, M.D. Tronko // Доповіді Національної академії наук України. — 2018. — № 11. — С. 91-95. — Бібліогр.: 11 назв. — англ.

The content of the brain natriuretic peptide (NT-proBNP) in blood plasma and the activity of 5′-adenosine monophosphate-
 activated protein kinase (AMPK) in lymphocytes of type 2 diabetes patients with anemia and after
 the treatment with dapagliflozin are determined with enzyme immu...